The FDA has authorized the first COVID-19 vaccine booster dose for American adolescents ages 12 to 15.
"Just to make sure every everyone is clear on this, right now: If you got [Johnson & Johnson’s one-dose], you get a booster after 2 months. If you got Moderna, you can get a booster at 6 months or beyond," she said during a media briefing.
The data so far consistently points to a higher risk of myocarditis after a second mRNA vaccine dose among males, from teenagers to 30-year-olds, with a peak at about 16 to 17 years of age, Peter Marks, MD, PhD, director of the FDA’s Center for Biologics Evaluation and Research, said during the media call.
"But what it is saying is that in the setting of a tremendous number of Omicron and Delta cases in this country, the potential benefits of getting vaccinated in this age group outweigh that risk," Marks said."We can look at that risk-benefit and still feel comfortable." "There was a mix-and-match study that was done which showed that in some cases, the mixing and matching … of an adenoviral record vaccine and an mRNA vaccine seem to give a very good immune response," Marks said.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
FDA authorizes Pfizer Covid-19 vaccine boosters for 12- to 15-year-oldsThe US kicked off 2022 amid a massive Covid-19 case spike — driven by the highly contagious Omicron variant — that some experts warn will be different than any other time in the pandemic.
Weiterlesen »
FDA expands Pfizer COVID-19 boosters for 12- to 15-year-olds as omicron surgesThe U.S. is expanding COVID-19 boosters as it confronts the omicron surge, with the FDA allowing extra Pfizer shots for children as young as 12.
Weiterlesen »
FDA Authorizes Pfizer Boosters for Kids Ages 12 to 15The U.S. is expanding COVID-19 boosters as it confronts a surge of infections nationwide, with the Food and Drug Administration allowing extra Pfizer shots for children as young as 12.
Weiterlesen »
FDA Expands Pfizer Booster Eligibility to Kids Ages 12 to 15New Covid infections have hit a pandemic high in the U.S. as the highly contagious omicron variant has supplanted delta as the dominant strain.
Weiterlesen »
FDA expands Pfizer COVID-19 vaccine booster for ages 12 to 15The FDA expanded Pfizer’s COVID-19 vaccine booster for kids as young as 12. Final approval from the CDC is still needed.
Weiterlesen »
U.S. FDA authorizes Pfizer's COVID-19 booster for 12- to 15-year-oldsThe U.S. Food and Drug Administration on Monday authorized the use of a third dose of the Pfizer and BioNTech COVID-19 vaccine for children ages 12 to 15, and narrowed the interval for booster shot eligibility to five months from six.
Weiterlesen »